METiS Pharmaceuticals Funding: $86M Raised, Series A (2021)
METiS Pharmaceuticals is based in Beijing, China. It has raised $86M in total funding. Latest round: Series A.
METiS Pharmaceuticals funding overview
METiS Pharmaceuticals is based in Beijing, China. METiS Pharmaceuticals has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for METiS Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital. 5 distinct backers are named across the disclosed rounds.
METiS Pharmaceuticals at a glance
Total raised
$86M
Latest round
Series A
Latest round date
December 2021
Headquarters
Beijing, China
Notable investors
PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital
Frequently asked about METiS Pharmaceuticals funding
How much has METiS Pharmaceuticals raised?
METiS Pharmaceuticals has raised $86M in total disclosed funding across the rounds on record.
Who has invested in METiS Pharmaceuticals?
PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital are named among the investors backing METiS Pharmaceuticals.
What was the latest METiS Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is METiS Pharmaceuticals based?
METiS Pharmaceuticals is based in Beijing, China.
When did METiS Pharmaceuticals last raise?
The last disclosed METiS Pharmaceuticals round closed in December 2021 at Series A.
METiS Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.
